Add BrightSurf on Google Email

University of Pittsburgh Medical Center


Gene therapy technique could aid islet transplants for diabetes, says Pittsburgh study

Researchers develop gene therapy to enhance islet cell function and survival after transplantation. The technique uses a growth factor DNA to induce cell division, improving insulin production and glucose control in rat models. However, standard immunosuppression drug therapy may be harmful, inducing insulin resistance and diabetes.

SourceUniversity of Pittsburgh Medical Center·JournalEndocrinology·DateFeb 4, 2004

Caregivers for patients with dementia need more support before patient dies, less after

A new study suggests that caregivers of patients with end-of-life dementia experience high levels of depressive symptoms while caring for their loved ones, but exhibit clinically lower depression after the patient's death. The research also found that caregivers report feeling relieved when their loved one passes away.

SourceUniversity of Pittsburgh Medical Center·JournalNew England Journal of Medicine·DateNov 12, 2003

Gastric bypass surgery resolves or improves diabetes in most patients, reports Pittsburgh study

The study found that gastric bypass surgery significantly improved diabetes outcomes in patients, with nearly all achieving normal blood sugar levels and reducing their reliance on anti-diabetic medications. Patients with shorter disease durations and milder type 2 diabetes saw the greatest improvements in glycemic control.

SourceUniversity of Pittsburgh Medical Center·JournalAnnals of Surgery·DateOct 2, 2003

University of Pittsburgh study links gynecological complaint to increased risk for herpes

A recent University of Pittsburgh study found that women with bacterial vaginosis (BV) are nearly twice as likely to get herpes simplex virus type 2 (HSV-2). The study, which involved over 1,200 sexually active women, suggests that more comprehensive screening and treatment could reduce susceptibility to HSV-2.

SourceUniversity of Pittsburgh Medical Center·JournalClinical Infectious Diseases·DateJul 22, 2003

Studies of liver transplant patients off anti-rejection drugs have altered cell profile

Researchers found a higher incidence of beneficial dendritic cells in weaned and nearly weaned liver transplant patients, compared to those on daily doses of anti-rejection drugs. This cellular profile is similar to that of healthy non-transplant patients, suggesting a possible test for predicting successful weaning.

SourceUniversity of Pittsburgh Medical Center·JournalAmerican Journal of Transplantation·DateJun 2, 2003